REFERENCIAS BIBLIOGRÁFICAS:
1. Wade SS, Stephen HL, Donal EJ. Enfermedades cerebrovasculares. En: Eugene Branwald. Principios de Medicina Interna. 16 Ed. México. Mc Graw Hill 2005; pg 2769 – 96.
2. Romero B., Aguilera J.M., Castela A. Enfermedad cerebrovascular. Medicine. 2007;9(72):4581-4588.
3. Tunstall Pedoe H, for the WHO Monica Project Principal Investigators The WorldHealth Organisation. Monica Project. J Clin Epidemiol 1988; 41: 105-14.
4. Villanueva JA. Enfermedad vascular cerebral: factores de riesgo y prevención secundaria. An Med Interna (Madrid) 2004; 21: 159-160.
5. González Casanova E, García Cabrera R, Rodríguez García-Casariego M. Factores de riesgo de las enfermedades cerebrovasculares en el municipio Ciego de Ávila. Enero-mayo de 2011. Cuba. MEDICIEGO 2013; 19(1).
6. Arboix A, Massons J, Oliveres M, García L, Titus F. Mortalidad en la fase aguda de la enfermedad cerebrovascular: registro de La Alianza-Hospital Central de Barcelona. Med Clin (Barc) 2005; 103: 529-33.
7. Carlberg B, Asplund K, Hagg E. Course of blood pressure in diferent subsets of patients after acute stroke. Cerebrovasc Dis 2006; 1: 281-7.
8. Rodríguez García PL. Examen clínico del paciente con ictus. Rev Cubana Neurol Neurocir. 2011;1(1):74–89.
9. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr; on behalf of the American Heart Association Stroke Council. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator. A science advisory from the American Heart Association/American Stroke Association. Stroke. 2009;40:2945–8.
10. Barrett KM, Levine JM, Johnston KC. Diagnosis of stroke and stroke mimics in the emergency setting. Continuum: Lifelong Learning Neurol. 2008;14:13–27.
11. Buergo Zuaznábar M, Fernández Concepción O. Guías de práctica clínica. Enfermedad cerebrovascular. Editorial de Ciencias Médicas, La Habana, 2009, pag. 11-14.
12. WHO. Neurological disorders : public health challenges. World Health Organization. 2006.
13. Truelsen T, Bonita R, Gronback M, Schnohr P, Boysen G. Stroke incidence and case fatality in two populations: the Auckland Stroke Study and the Copenhagen City Heart Study. Neuroepidemiology 2006; 17: 132-8.
14. Lennart W, Suardsudd K, Wilhelmsem L, Larsson B, Tibblin G. Analysis of risk factors for stroke in a cohort of men born in 1913. N Engl J Med 2006; 317(9):521-5.
15. Dirección Nacional de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud, 2011. Edición Especial, La Habana, 2012. pag 43-71.
16. Varona Arche, J. Ictus en el paciente adulto joven. Etiología y pronóstico a largo plazo. Tesis Doctoral, Madrid, 2003. [Consultado: 4 Abril 2013] Disponible en URL:
http://pendientedemigracion.ucm.es/BUCM/tesis/med/ucm-t26848.pdf
17. K Lipska, P N Sylaja, P S Sarma, K R Thankappan, V R Kutty, R S Vasan, K Radhakrishnan. Risk factors for acute ischaemic stroke in young adults in South India. J NeurolNeurosurgPsychiatry 2007;78:959–963.
18. Nencini P, Inzitari D, Baruffi MC, Fratiglioni L, Gagliardi R, Benevuti T et al. Incidence of stroke in young adults in Florence, Italy. Stroke 1988; 19:977-981.
19. Leno C, Berciano J, Combarros O, Polo JM, Pascual J, Quintana F et al. A prospective study of Stroke in young adults in Cantabria, Spain. Stroke 1993; 24: 792-795.
20. Qureshi AI, Safdar K, Patel M, JanssenRS, Frankel MR. Strokein youngblackpatients. Riskfactors, subtypes, and prognosis. Stroke 1995; 26:1995-1998.
21. Hernández Iglesias M, González García V, Bustamante Rojas R, et al. Comportamiento de la enfermedad cerebrovascular en el adulto joven en el Hospital «General Calixto García». Rev cubana med; 2001; v.41 n.5 .
22. Rozenthul-Sorokin N, Ronen R, Tamir A, Geva H, Eldar R. Stroke in theyoung in Israel. Stroke 1996; 27: 838-841.
23. Finley Caulfield A, Christine AC, Wijman, MD. Management of Acute Ischemic Stroke. Department of Neurology and Neurological Sciences, Neurocritical Care Program, Stanford Stroke Center, Stanford University School of Medicine, USA NeurolClin 26 (2008) 345–371.
24. Van der Worp HB, Raaijmakers TW, Kappelle LJ. Early complications of ischemic stroke. Curr Treat Options Neurol. 2008; 10(6):440-9.
25. Thanvi B, Treadwell S, Robinson T. Early neurological deterioration in acute ischaemic stroke: predictors, mechanisms and management. Postgrad Med J. 2008; 84(994):412-7.
26. The International Stroke Trial Collaborative Group: The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither, among 19,435 patients with acute ischaemic stroke. Lancet 1997; 349: 1569-1581.
27. CAST (Chinese Acute Stroke Trial) Collaborative Group: CAST: randomised placebo – controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 1997; 349: 1641- 1649.
28. Adams H, Adams R, Del Zoppo G, et al. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines updateda scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 2005;36:916–23.
29. Pérez Nellar J, Scherle Matamoros C, Roselló Silva H. Unidad de Ictus Agudo. Un nuevo concepto asistencial. Cuba. Rev Acta Médica, 2009. vol 12, no.1.